vs
德康医疗(DXCM)与SUN COMMUNITIES INC(SUI)财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是SUN COMMUNITIES INC的1.8倍($1.3B vs $697.2M),德康医疗净利率更高(21.2% vs 1.7%,领先19.5%),德康医疗同比增速更快(21.6% vs -25.8%),过去两年德康医疗的营收复合增速更高(12.0% vs -2.1%)
德康医疗是美国跨国医疗保健企业,专注于研发、生产及销售糖尿病管理领域的连续血糖监测(CGM)系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥,生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Sun Communities是一家上市房地产投资信托基金,核心投资品类为预制住宅社区及房车营地物业。截至2025年6月2日,该公司在美国、加拿大、英国三地合计持有500处相关资产的权益,专注于居住及休闲类不动产投资领域。
DXCM vs SUI — 直观对比
营收规模更大
DXCM
是对方的1.8倍
$697.2M
营收增速更快
DXCM
高出47.4%
-25.8%
净利率更高
DXCM
高出19.5%
1.7%
两年增速更快
DXCM
近两年复合增速
-2.1%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.3B | $697.2M |
| 净利润 | $267.3M | $12.1M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | — |
| 净利率 | 21.2% | 1.7% |
| 营收同比 | 21.6% | -25.8% |
| 净利润同比 | 153.6% | -96.0% |
| 每股收益(稀释后) | $0.67 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DXCM
SUI
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $697.2M | ||
| Q2 25 | $1.2B | $623.5M | ||
| Q1 25 | $1.0B | $470.2M | ||
| Q4 24 | $1.1B | $745.9M | ||
| Q3 24 | $994.2M | $939.9M | ||
| Q2 24 | $1.0B | $864.0M |
净利润
DXCM
SUI
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $12.1M | ||
| Q2 25 | $179.8M | $1.3B | ||
| Q1 25 | $105.4M | $-41.2M | ||
| Q4 24 | $151.7M | $-228.4M | ||
| Q3 24 | $134.6M | $300.5M | ||
| Q2 24 | $143.5M | $56.7M |
毛利率
DXCM
SUI
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率
DXCM
SUI
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
净利率
DXCM
SUI
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 1.7% | ||
| Q2 25 | 15.5% | 210.8% | ||
| Q1 25 | 10.2% | -8.8% | ||
| Q4 24 | 13.6% | -30.6% | ||
| Q3 24 | 13.5% | 32.0% | ||
| Q2 24 | 14.3% | 6.6% |
每股收益(稀释后)
DXCM
SUI
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | $0.07 | ||
| Q2 25 | $0.45 | $10.02 | ||
| Q1 25 | $0.27 | $-0.34 | ||
| Q4 24 | $0.37 | $-1.80 | ||
| Q3 24 | $0.34 | $2.31 | ||
| Q2 24 | $0.35 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $542.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $7.0B |
| 总资产 | $6.3B | $12.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DXCM
SUI
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | $542.7M | ||
| Q2 25 | $1.2B | $889.7M | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | $47.4M | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
总债务
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.4B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
DXCM
SUI
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | $7.0B | ||
| Q2 25 | $2.6B | $7.4B | ||
| Q1 25 | $2.3B | $6.9B | ||
| Q4 24 | $2.1B | $7.1B | ||
| Q3 24 | $2.0B | $7.5B | ||
| Q2 24 | $2.4B | $6.9B |
总资产
DXCM
SUI
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | $12.8B | ||
| Q2 25 | $7.3B | $13.4B | ||
| Q1 25 | $6.8B | $16.5B | ||
| Q4 24 | $6.5B | $16.5B | ||
| Q3 24 | $6.4B | $17.1B | ||
| Q2 24 | $6.8B | $17.0B |
负债/权益比
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $197.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 16.35× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | — | ||
| Q3 25 | $659.9M | $197.8M | ||
| Q2 25 | $303.0M | $256.0M | ||
| Q1 25 | $183.8M | $243.9M | ||
| Q4 24 | $301.4M | $118.0M | ||
| Q3 24 | $199.5M | $189.2M | ||
| Q2 24 | $279.4M | $311.3M |
自由现金流
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
自由现金流率
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
资本支出强度
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
现金转化率
DXCM
SUI
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 16.35× | ||
| Q2 25 | 1.69× | 0.19× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 0.63× | ||
| Q2 24 | 1.95× | 5.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图